跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vicolax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vicolax
Approved
STANDARD
Vicolax
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
78717f1e7e7c7909
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
78717f1e7e7c7909
Drug Approval Philippines Name
Vicolax
Product Name
Vicolax
Registration Number
DR-XY26582
Brand Name
Vicolax
Generic Name
Guaifenesin + Salbutamol
Dosage Form
Tablet
Dosage Strength
100 mg/2 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Vitalink Health Products, Inc.
Distributor
Vita Care Pharma Enterprises
Issuance Date
24 January 2025
Expiry Date
21 September 2025
Pharmacologic Category
Expectorant/ Selective Beta-2-Adrenoreceptor Agonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
78717f1e7e7c7909
Type
Standard
Back to Philippines FDA Approvals